Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clumping factor A (ClfA) is a cell surface-associated protein and a major virulence factor produced by Staphylococcus aureus. It binds to the gamma-chain of human fibrinogen, promoting bacterial adhesion to host tissues and medical devices, facilitating biofilm formation and infection persistence. It also inhibits phagocytosis by immune cells. ClfA is being investigated as a vaccine target.
Dock, lock, and latch (DLL) mechanism to bind fibrinogen γ-chain. Promotes bacterial adhesion under shear stress. Can inhibit phagocytosis through complement regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clumping factor A (None).